Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Reminder: Utilization management program for genetic/genomic tests, certain molecular analyses, and cytogenetic tests

May 1, 2017

[

Last year, Independence introduced a new utilization management program for genetic/genomic tests, certain molecular analyses, and cytogenetic tests for all commercial Independence members. We are working with CareCore National, LLC d/b/a eviCore healthcare (eviCore), an independent specialty benefit management company, to manage precertification and/or prepayment coverage reviews for these tests.

Please note that the ordering provider is responsible for submitting the precertification requests for the applicable tests.

Precertification requirements

Ordering health care providers must contact eviCore to obtain precertification for certain genetic/genomic tests, including, but not limited to, the following:*

  • BRCA gene testing
  • genetic panels and cancer gene expression tests
  • genome-wide tests
  • pharmacogenomic tests

You can access the Independence Blue Cross Prior Authorization Procedure Lists on eviCore?s website.

Submitting requests to eviCore

You can initiate precertification for genetic/genomic tests in one of the following ways:

  • NaviNet? web portal. Select CareCore from the Authorizations option in the Independence Workflows menu.
  • Telephone. Call eviCore directly at 1-866-686-2649.

Important information for laboratories

When a request for genetic/genomic testing is received, laboratories must ensure a precertification is on file before rendering services. If precertification is not on file for the member, it is the laboratory?s responsibility to submit a request to eviCore.

Prepayment review

All genetic/genomic tests, along with certain molecular analyses and cytogenetic tests, are reviewed by eviCore prior to final claim adjudication and any payment (if applicable). Examples of molecular analyses and cytogenetic tests include, but are not limited to, the following:*

  • comparative genomic hybridization (CGH)
  • flow cytometry
  • fluorescent in situ hybridization (FISH)
  • immunohistochemistry (IHC)
  • morphometric analyses

Lab management policy and guidelines

Review Medical Policy #06.02.52d: eviCore Lab Management Program for more information about the utilization management program. The policy includes a link to the Lab Management Program Clinical Guidelines that eviCore uses during the precertification and prepayment review processes, as well as a listing of procedure codes requiring precertification and/or prepayment review.

To view this policy, visit our Medical Policy Portal. Select Accept and Go to Medical Policy Online, then select the Commercial tab from the top of the page and type the policy name or number in the Search field.

More information

If you have questions about any of these requirements, you can contact your Network Coordinator or call Customer Service at 1-800-ASK-BLUE.

*This list of services is subject to change.

NaviNet is a registered trademark of NaviNet, Inc., an independent company.

]

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2023 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.